UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000019303
Receipt number R000022321
Scientific Title Phase II clinical trial of pazopanib with unresectable or metastatic malignant peripheral nerve sheath tumor (1st cohort) and in patients with chemoresistant tumors; alveolar soft part sarcoma, epithelioid sarcoma, and clear cell sarcoma (2nd cohort)
Date of disclosure of the study information 2015/10/09
Last modified on 2022/04/14 10:37:00

No. Disposal Last modified on Item of update
1 Insert 2015/10/09 20:18:55
2 Update 2015/10/15 01:08:09 Organization
Organization
Category of Funding Organization
Co-sponsor
Co-sponsor
3 Update 2016/01/20 21:06:49 Institute
Institute
Organization
Organization
Category of Funding Organization
4 Update 2016/08/05 10:38:27 Name of primary person or sponsor
Organization
Organization
5 Update 2016/08/05 10:39:31 Recruitment status
6 Update 2016/08/05 10:41:02 Genomic information
7 Update 2019/04/12 09:54:08 Recruitment status
Date of IRB
Anticipated trial start date
Last follow-up date
8 Update 2019/08/09 17:39:26 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
9 Update 2019/08/09 17:41:05 Number of participants that the trial has enrolled
10 Update 2022/04/14 10:35:18 URL releasing protocol
URL related to results and publications
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
11 Update 2022/04/14 10:35:52 Recruitment status
12 Update 2022/04/14 10:36:37 Last follow-up date
13 Update 2022/04/14 10:37:00 Publication of results